Preferred Label : alanine;
MeSH definition : A non-essential amino acid that occurs in high levels in its free state in plasma.
It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism,
increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL
NERVOUS SYSTEM.;
MeSH synonym : l-isomer alanine; l alanine; alanine, l-isomer; alanine, l isomer; l-alanine;
CISMeF synonym : Doms-Adrian brand of alanine; alanine Doms-Adrian brand; doms adrian brand of alanine;
DeCS synonym : Abuf ne;
MeSH hyponym : abufène;
MeSH CAS label : (L)-Alanine;
MeSH Related Number : 56-41-7 (Alanine); 6898-94-8;
Registry Number MeSH : 56-41-7;
MeSH annotation : BETA-ALANINE is also available;
Wikipedia link : https://en.wikipedia.org/wiki/Alanine;
Codes EINECS : 200-273-8;
Is substance : O;
medicament (CISMeF) : O;
UNII : OF5P57N2ZX;
InChIKey : QNAYBMKLOCPYGJ-REOHCLBHSA-N;
Origin ID : D000409;
UMLS CUI : C0001898;
Allowable qualifiers
CISMeF manual mappings
Currated CISMeF NLP mapping
- alanine [Artificial nutrition thesaurus concept]
- alanine [International Nonproprietary Name]
Indexing information
Record concept(s)
Related MeSH Supplementary Concept(s)
- AD 20 [MeSH Supplementary Concept]
- AD 5 [MeSH Supplementary Concept]
- BMS 824 [MeSH Supplementary Concept]
- CPW 399 [MeSH Supplementary Concept]
- GS-6620 [MeSH Supplementary Concept]
- HAO472 [MeSH Supplementary Concept]
- MK 0642 [MeSH Supplementary Concept]
- OSU8 1 [MeSH Supplementary Concept]
- QYL 609 [MeSH Supplementary Concept]
- QYL 685 [MeSH Supplementary Concept]
- RB 120 [MeSH Supplementary Concept]
- SJ874 [MeSH Supplementary Concept]
- UBP 310 [MeSH Supplementary Concept]
- UBP296 [MeSH Supplementary Concept]
- XP 280 [MeSH Supplementary Concept]
- XV 454 [MeSH Supplementary Concept]
- alacide [MeSH Supplementary Concept]
- aladan [MeSH Supplementary Concept]
- cf 1001 [MeSH Supplementary Concept]
- cf 1093 [MeSH Supplementary Concept]
- so 324 [MeSH Supplementary Concept]
See also (suggested by CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
- alanine [International Nonproprietary Name]
A non-essential amino acid that occurs in high levels in its free state in plasma.
It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism,
increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL
NERVOUS SYSTEM.
https://pgtmsite.files.wordpress.com/2024/01/ad_covid-ambulatoire-pediatrie_vf2_20230405.pdf
https://pgtmsite.files.wordpress.com/2024/01/poster_covid-adulte-et-ped_apes_-2023_final-1.pdf
2023
false
false
false
Canada
antibodies, monoclonal, humanized
antibodies, neutralizing
alanine
adenosine monophosphate
ribonucleotides
pediatrics
alanine
adenosine monophosphate
ribonucleotides
guidelines for drug use
remdesivir
sotrovimab
outpatients
hospitals, university
COVID-19
quebec
---
https://www.inesss.qc.ca/covid-19/traitements-specifiques-a-la-covid-19/remdesivir.html
2022
false
false
false
Canada
French
drug evaluation
treatment outcome
remdesivir
Remdesivir
antiviral agents
Evidence-Based medicine
remdesivir
alanine
alanine
ribonucleotides
pneumonia, viral
coronavirus infections
pandemics
COVID-19
---
https://www.has-sante.fr/upload/docs/application/pdf/2021-02/veille_covid_fevrier_2021.pdf
2021
false
false
false
France
French
drug information
scientific and technical information
review of literature
remdesivir
dexamethasone
glucocorticoids
COVID-19-Associated Acute Respiratory Distress Syndrome
cytokine storm syndrome
antiviral agents
lopinavir-ritonavir drug combination
azithromycin
hydroxychloroquine
tocilizumab
interleukin 1 receptor antagonist protein
treatment outcome
canakinumab
Post-Exposure prophylaxis
antibodies, monoclonal, humanized
Etesevimab
Bamlanivimab
Casirivimab
Imdevimab
Casirivimab/Imdevimab
colchicine
ivermectin
vitamin D
COVID-19 Convalescent Plasma
bamlanivimab
cytokine storm syndrome in COVID-19
alanine
alanine
ribonucleotides
pandemics
antibodies, monoclonal
ritonavir
lopinavir
drug combinations
immunization, passive
COVID-19
COVID-19
COVID-19
---
https://publications.msss.gouv.qc.ca/msss/document-002960/
2021
false
false
false
Canada
coronavirus infections
pneumonia, viral
public health guidelines
remdesivir
guideline
Researches
research
guideline
pandemics
alanine
ribonucleotides
COVID-19
---
https://www.cbip.be/fr/articles/3510?folia=3503
2021
false
false
false
Belgium
French
journal article
hydroxychloroquine
Remdesivir
remdesivir
lopinavir
Interferon beta-1a
treatment outcome
inpatients
controlled clinical trials as topic
pneumonia, viral
coronavirus infections
pandemics
coronavirus infections
alanine
alanine
ribonucleotides
pneumonia, viral
coronavirus infections
pandemics
COVID-19
COVID-19
---
https://www.has-sante.fr/jcms/p_3186049/fr/veille-des-etudes-cliniques-publiees-pour-certains-medicaments-du-covid-19
2021
false
false
false
France
coronavirus infections
pneumonia, viral
review of literature
hydroxychloroquine
remdesivir
lopinavir-ritonavir drug combination
Clinical Studies as Topic
azithromycin
remdesivir
pneumonia, viral
coronavirus infections
pandemics
alanine
alanine
ribonucleotides
ritonavir
lopinavir
drug combinations
COVID-19
---
https://www.cochrane.org/fr/CD014962/HAEMATOL_remdesivir-dans-le-traitement-des-personnes-atteintes-de-la-covid-19
2021
false
false
false
France
United Kingdom
COVID-19
adenosine monophosphate
alanine
antiviral agents
review of literature
french abstract
remdesivir
---
https://presse.inserm.fr/absence-defficacite-du-remdesivir-chez-les-patients-hospitalises-atteints-de-covid-19-et-poursuite-de-lessai-discovery-pour-tester-un-nouveau-medicament-antiviral/43790
2021
false
false
false
France
French
journal article
coronavirus infections
alanine
alanine
ribonucleotides
adenosine monophosphate
adenosine monophosphate
COVID-19
treatment outcome
remdesivir
antiviral agents
medical futility
Lack of drug action (finding)
inpatients
---
https://saez.swisshealthweb.ch/fr/article/doi/bms.2021.19636
2021
Switzerland
pneumonia, viral
coronavirus infections
journal article
remdesivir
pandemics
alanine
ribonucleotides
COVID-19
---
https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=847
2020
false
false
true
France
pneumonia, viral
coronavirus infections
hydroxychloroquine
lopinavir-ritonavir drug combination
Remdesivir
remdesivir
clinical trials as topic
Symptomatic treatment
public health guidelines
pandemics
pneumonia, viral
coronavirus infections
pandemics
ritonavir
lopinavir
drug combinations
alanine
alanine
ribonucleotides
COVID-19
---
https://www.inesss.qc.ca/covid-19/traitements-specifiques-a-la-covid-19/remdesivir.html
2020
false
false
false
Canada
pneumonia, viral
coronavirus infections
drug evaluation
remdesivir
pandemics
alanine
ribonucleotides
COVID-19
---
https://www.has-sante.fr/jcms/p_3201793/fr/veklury
2020
false
false
false
France
Remdesivir
remdesivir
treatment outcome
infusions, intravenous
insurance, health, reimbursement
adolescent
antiviral agents
remdesivir
evaluation of the transparency committee
alanine
alanine
ribonucleotides
pneumonia, viral
coronavirus infections
pandemics
coronavirus infections
COVID-19
---
https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=899
2020
false
false
false
France
coronavirus infections
pneumonia, viral
risk factors
prognosis
severity of illness index
comorbidity
anti-bacterial agents
azithromycin
amoxicillin-potassium clavulanate combination
ceftriaxone
glucocorticoids
extracorporeal membrane oxygenation
ventilation, mechanical
antiviral agents
drug interactions
lopinavir-ritonavir drug combination
hydroxychloroquine
Remdesivir
remdesivir
convalescent plasma
immunologic factors
chloroquine
tocilizumab
Interleukin Inhibitor
practice guideline
public health guidelines
patient care management
respiration, artificial
pneumonia, viral
coronavirus infections
pandemics
Betacoronavirus
pneumonia, viral
coronavirus infections
pandemics
pneumonia, viral
coronavirus infections
pandemics
pneumonia, viral
coronavirus infections
pandemics
ritonavir
lopinavir
drug combinations
alanine
alanine
ribonucleotides
immunization, passive
antibodies, monoclonal, humanized
COVID-19
COVID-19
COVID-19
COVID-19
COVID-19
---
https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=897
2020
false
false
false
France
coronavirus infections
pneumonia, viral
Remdesivir
antiviral agents
public health guidelines
remdesivir
pneumonia, viral
coronavirus infections
pandemics
alanine
alanine
ribonucleotides
COVID-19
---
Remdesivir authorized with conditions for the treatment of patients in Canada with
severe COVID-19 symptoms
https://canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2020/73621a-fra.php
2020
false
false
false
Canada
French
English
drug information
drug approval
canada
oxygen inhalation therapy
remdesivir
Remdesivir
adult
adolescent
infusions, intravenous
antiviral agents
product surveillance, postmarketing
pneumonia, viral
coronavirus infections
pandemics
coronavirus infections
alanine
alanine
ribonucleotides
COVID-19
---
https://www.ema.europa.eu/en/medicines/human/EPAR/veklury
2020
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
remdesivir
remdesivir
Remdesivir
adult
adolescent
infusions, intravenous
antiviral agents
antiviral agents
RNA Polymerase Inhibitor
product surveillance, postmarketing
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
oxygen inhalation therapy
remdesivir
alanine
alanine
ribonucleotides
alanine
ribonucleotides
pneumonia, viral
coronavirus infections
pandemics
coronavirus infections
COVID-19
---
https://www.ansm.sante.fr/actualites/covid-19-octroi-dune-atu-de-cohorte-pour-le-medicament-remdesivir-afin-que-les-patients-puissent-continuer-a-en-beneficier-en-france
2020
false
false
false
France
French
drug information
france
Remdesivir
antiviral agents
remdesivir
hospitals
adult
adolescent
guidelines for drug use
patient education handout
pneumonia, viral
coronavirus infections
pandemics
coronavirus infections
alanine
alanine
ribonucleotides
COVID-19
---
https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=866
2020
false
false
false
France
coronavirus infections
pneumonia, viral
standard of care
chloroquine
hydroxychloroquine
remdesivir
lopinavir-ritonavir drug combination
immunotherapy
siltuximab
tocilizumab
sarilumab
umifenovir
convalescent plasma
dexamethasone
public health guidelines
pneumonia, viral
coronavirus infections
pandemics
alanine
alanine
ribonucleotides
ritonavir
lopinavir
drug combinations
pneumonia, viral
coronavirus infections
pandemics
antibodies, monoclonal
antibodies, monoclonal, humanized
indoles
COVID-19
COVID-19
---
https://www.inesss.qc.ca/covid-19/traitements-specifiques-a-la-covid-19/remdesivir.html
2020
false
false
false
Canada
French
guidelines for drug use
treatment outcome
remdesivir
Remdesivir
antiviral agents
canada
remdesivir
alanine
alanine
ribonucleotides
pneumonia, viral
coronavirus infections
pandemics
coronavirus infections
COVID-19
---
https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=854
2020
false
false
false
France
pneumonia, viral
coronavirus infections
Remdesivir
remdesivir
antiviral agents
remdesivir
treatment outcome
risk assessment
Clinical Studies as Topic
antiviral agents
remdesivir
public health guidelines
pneumonia, viral
coronavirus infections
pandemics
alanine
alanine
ribonucleotides
alanine
ribonucleotides
COVID-19
---
https://www.coreb.infectiologie.com/UserFiles/File/procedures/tt-specifiques-covid-si-va-9-avr-20.pdf
2020
false
false
false
France
consensus
coronavirus infections
pneumonia, viral
critical care
ventilation, mechanical
coronavirus infections
antiviral agents
Remdesivir
lopinavir-ritonavir drug combination
chloroquine
antibodies, monoclonal
umifenovir
coronavirus infections
COVID-19
remdesivir
case management
resuscitation
respiration, artificial
ritonavir
lopinavir
drug combinations
indoles
pneumonia, viral
alanine
ribonucleotides
COVID-19
---
https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=771
2020
false
false
false
France
coronavirus infections
coronavirus infections
pneumonia, viral
pneumonia, viral
practice guideline
coronavirus infections
coronavirus infections
disease transmission, infectious
coronavirus infections
signs and symptoms
adult
child
pregnancy
pneumonia, viral
risk factors
remdesivir
Remdesivir
hospitalization
coronavirus infections
lopinavir-ritonavir drug combination
chloroquine
antiviral agents
severity of illness index
continuity of patient care
coronavirus infections
COVID-19
public health guidelines
patient care management
alanine
alanine
ribonucleotides
ritonavir
lopinavir
drug combinations
pneumonia, viral
COVID-19
---
https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=785
https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=787
2020
false
false
false
France
Off-Label use
severity of illness index
oxygen inhalation therapy
hospitalization
lopinavir-ritonavir drug combination
remdesivir
Remdesivir
hydroxychloroquine
Respiratory Distress Syndrome
antiviral agents
azithromycin
drug interactions
drug monitoring
antiviral agents
antiviral agents
practice guideline
adult
aged
hypoxemia
signs and symptoms
risk factors
reverse transcriptase polymerase chain reaction
clinical trials as topic
public health guidelines
case management
pneumonia, viral
coronavirus infections
Hypoxia
pneumonia, viral
coronavirus infections
pneumonia, viral
coronavirus infections
ritonavir
lopinavir
drug combinations
alanine
alanine
ribonucleotides
pneumonia, viral
coronavirus infections
COVID-19
COVID-19
COVID-19
COVID-19
---
https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=695
2018
false
false
false
France
French
public health guidelines
hemorrhagic fever, ebola
hemorrhagic fever, ebola
health personnel
occupational exposure
Pre-Exposure Prophylaxis
Post-Exposure prophylaxis
ebola vaccines
antibodies, monoclonal
antiviral agents
ZMapp
Remdesivir
favipiravir
remdesivir
amides
pyrazines
alanine
alanine
ribonucleotides
---
https://www.ema.europa.eu/medicines/human/EPAR/Xadago
2015
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
safinamide
safinamide
drug therapy, combination
levodopa
parkinson disease
On - off phenomenon (disorder)
administration, oral
product surveillance, postmarketing
safinamide methanesulfonate
safinamide methanesulfonate
antiparkinson agents
antiparkinson agents
adult
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
monoamine oxidase inhibitors
monoamine oxidase inhibitors
reversible inhibitors of monoamine oxidase
monoamine oxidase B
safinamide
monoamine oxidase
monoamine oxidase inhibitors
alanine
alanine
benzylamines
alanine
benzylamines
---
http://www.has-sante.fr/portail/jcms/c_2569071/fr/xadago
http://www.has-sante.fr/portail/jcms/c_2569071/fr/xadago-safinamide-antiparkinsonien
2015
false
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
insurance, health, reimbursement
safinamide methanesulfonate
safinamide methanesulfonate
administration, oral
adult
drug therapy, combination
parkinson disease
monoamine oxidase inhibitors
monoamine oxidase inhibitors
guidelines for drug use
Motor fluctuations
safinamide
safinamide
safinamide
benzylamines
alanine
alanine
benzylamines
alanine
---
https://reptox.cnesst.gouv.qc.ca/pages/fiche-complete.aspx?no_produit=52993&nom=Alanine+(dl-)
Canada
toxicological data sheet
alanine
---
https://reptox.cnesst.gouv.qc.ca/pages/fiche-complete.aspx?no_produit=147728&nom=Alanine+(d-)
Canada
toxicological data sheet
alanine
---
https://reptox.cnesst.gouv.qc.ca/pages/fiche-complete.aspx?no_produit=107680&nom=Alanine+(l-)
Canada
toxicological data sheet
alanine
---
https://reptox.cnesst.gouv.qc.ca/pages/fiche-complete.aspx?no_produit=129759&nom=Alanine+(bêta-)
Canada
toxicological data sheet
alanine
---
http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=FR&Expert=100924
2011
France
scientific and technical information
alanine
aminolevulinic acid
porphyrias
---
http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=FR&Expert=93598
2011
France
scientific and technical information
transaminases
alanine
glycols
glyoxylate
primary hyperoxaluria type 1
hyperoxaluria, primary
---
http://www.has-sante.fr/portail/jcms/c_523276/perikabiven
2007
France
French
potassium chloride
glucose
glycine
histidine
aspartic acid
arginine
proline
emulsions
perfusion
valine
tryptophan
potassium
lysine
magnesium sulfate
serine
alanine
threonine
methionine
sodium
calcium chloride
leucine
tyrosine
phenylalanine
calcium
magnesium
glycerophosphates
glutamic acid
alpha-glycerophosphoric acid
combinations
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/display.jsp?id=c_398910
2001
France
French
glucose
glycine
histidine
aspartic acid
arginine
proline
emulsions
perfusion
valine
tryptophan
potassium
lysine
magnesium sulfate
serine
alanine
threonine
methionine
sodium
calcium chloride
leucine
tyrosine
phenylalanine
calcium
magnesium
glycerophosphates
glutamic acid
potassium chloride
alpha-glycerophosphoric acid
combinations
evaluation of the transparency committee
---